$312.86
-1.29-0.41%
Last update: Nov 10, 10:44 AM
Ligand Pharmaceuticals Inc
LGNDNASDAQ
The average analyst price target for Ligand Pharmaceuticals is $302.92, 3.2% below the current price. Of 10 analysts, 10 rate it Buy. Targets range from $140 to $402. The latest change came on Nov 5, 2026, when Citigroup raised its price target on Ligand Pharmaceuticals from $397 to $402 and kept a Buy rating.
Price Target Range — 13 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months
